Walmart upgraded, Starbucks downgraded: Wall Street’s top analyst calls
PremiumThe FlyWalmart upgraded, Starbucks downgraded: Wall Street’s top analyst calls
2M ago
Protagonist Therapeutics initiated with a Buy at TD Cowen
Premium
The Fly
Protagonist Therapeutics initiated with a Buy at TD Cowen
2M ago
Protagonist Therapeutics Board and Audit Committee Changes
Premium
Company Announcements
Protagonist Therapeutics Board and Audit Committee Changes
2M ago
Protagonist Therapeutics sees cash runway through end of 2027
PremiumThe FlyProtagonist Therapeutics sees cash runway through end of 2027
3M ago
Protagonist Therapeutics reports Q2 EPS (50c), consensus (60c)
Premium
The Fly
Protagonist Therapeutics reports Q2 EPS (50c), consensus (60c)
3M ago
Protagonist Therapeutics announces publication of clinical data on JNJ-2113
Premium
The Fly
Protagonist Therapeutics announces publication of clinical data on JNJ-2113
3M ago
Rani Therapeutics price target raised to $14 from $7 at BTIG
PremiumThe FlyRani Therapeutics price target raised to $14 from $7 at BTIG
6M ago
Protagonist Therapeutics price target raised to $45 from $42 at JMP Securities
Premium
The Fly
Protagonist Therapeutics price target raised to $45 from $42 at JMP Securities
6M ago
Protagonist Therapeutics reports Q1 EPS $3.26, consensus $1.19
Premium
The Fly
Protagonist Therapeutics reports Q1 EPS $3.26, consensus $1.19
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100